A simple HPLC method for simultaneous determination of lopinavir/ritonavir and efavirenz

IRYO - Japanese Journal of National Medical Services

Volumn 58, Issue 2, 2004, Pages 102-104

  Usami, Yoshiko ^a   Oki, Tsuyoshi ^b   Nakai, Masahiko ^b   Sagisaka, Masafumi ^b   Kaneda, Tsuguhiro ^b  

^a NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; EFAVIRENZ; LOPINAVIR; METHANOL; RITONAVIR;

CHROMATOGRAPHY; CONFERENCE PAPER; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS; ROOM TEMPERATURE;

EID: 1942421349     PISSN: 00211699     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Kumar GN, Rodrigues AD, Buko AM et al: Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes. J Pharmacol Exp Ther 277: 423-431, 1996
2. Kumar GN, Jayanti V, Lee RD et al: In vitro metabolism of the HIV-1 protease inhibitor ABT-378: species comparison and metabolite identification. Drug Metab Dispos 27: 86-91, 1999
3. Adkins JC, Noble S: Efavirenz. Drugs 56: 1055-1064, 1998
4. Product information, Kaletra (lopinavir/ritonavir), Abbott Park, IL: Abbott Laboratories, 2000
5. Product information, Sustiva (efavirenz), Wilmington, DE: DuPont Pharmaceuticals Company, 2001